Central Valley Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Central Valley Advisors's LLY Position: Q3 2026 in Review
Central Valley Advisors reduced its Eli Lilly (LLY) stake by 33% in Q3 2026, selling an estimated $122K and leaving 207 shares worth $240K. The position accounts for 0.06% of the portfolio, ranked #145.
Central Valley Advisors first reported a position in LLY in Q1 2024 and has held it in 5 quarters since. The position peaked at $372K in Q2 2026. 4,568 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Central Valley Advisors held 207 shares of Eli Lilly worth $240K as of Q3 2026.
- Central Valley Advisors sold 103 Eli Lilly shares in Q3 2026, an estimated $122K.
- Eli Lilly made up 0.06% of Central Valley Advisors's portfolio in Q3 2026, its #145 holding.
- Central Valley Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 5 quarters since.
- Central Valley Advisors's Eli Lilly position peaked at $372K in Q2 2026.
- 4,568 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Central Valley Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.